Search clinical trials for: Fluticasone Furoate Nasal Spray

Total 602 results

Toby Weingarten

Completed

Nicotine Administration and Post-operative Opioid Use With Bariatric Surgery

Pain, Postoperative

United States
Janssen Research & Development, LLC

Completed

A Long-term Safety Study of Esketamine Nasal Spray in Treatment-resistant Depression (SUSTAIN-3)

Depressive Disorder, Treatment-Resistant

United States, France, Poland, United Kingdom, Belgium, Germany, Taiwan, Spain, Argentina, Mexico, Bulgaria, Malaysia, South Africa, Turkey, Canada, Korea, Republic of, Brazil, Estonia, Hungary, Lithuania, Slovakia, Sweden, Czechia, A... and more
Marinomed Biotech AG

Completed

Demonstration of a Decongestant Effect of "Coldamaris Akut" Compared to Saline Nasal Spray.

Allergic Rhinitis | Allergic Rhinoconjunctivitis

Austria
Bayer

Completed

Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934 (DIALOGUE5)

Renal Insufficiency, Chronic | Anemia

United States, Japan
Bitop AG

Completed

Non-interventional Study of Ectoin Nasal Douche (END01) in Patients With Acute Viral Rhinosinusitis

Acute Rhinosinusitis

Germany
Susanna Naggie, MD
Vanderbilt University Medical Center; National Center for Advancing Translational...

Completed

ACTIV-6: COVID-19 Study of Repurposed Medications - Arm C (Fluticasone)

Covid19

United States
Vance Thompson Vision - MT

Not yet recruiting

IIT Assessing OC-01Nasal Spray on Symptoms of DED Following CXL

Dry Eye Disease

United States
Chemi-Pharm AS

Recruiting

The Efficacy and Safety of BioBlock® Intranasally Administered Virus-Neutralizing Bovine Colostrum Nasal Spray in Preventing of COVID-19 (Coronavirus Disease-19) Infection in Healthy Volunteer Individuals

SARS CoV 2 Infection

Estonia
Lukas Pezawas

Recruiting

Add-on Therapy With Edupression.Com® on Therapy Resistant Depressive Patients Treated With Nasal Esketamine Spray (Esketamin+)

Major Depressive Disorder | Therapy Resistant Depression

Austria
University Children's Hospital Basel
Swiss National Science Foundation

Completed

Breath Metabolomics of Placebo Effects, a Pilot Study (BMPE)

Analgesia

Switzerland
GlaxoSmithKline

Completed

Study In Adults And Adolescents With Seasonal Allergic Rhinitis

Rhinitis, Allergic, Seasonal | Seasonal Allergic Rhinitis | Hayfever

United States
Ji Xing Pharmaceuticals (Shanghai) Co., Ltd.
Oyster Point Pharma, Inc.

Completed

Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease

Dry Eye Disease

China
GlaxoSmithKline

Completed

Study to Look at and Compare How Inhaled and Intravenous Fluticasone Furoate is Processed by the Body in Healthy Caucasian, Japanese, Korean and Chinese Subjects

Asthma

Australia
GlaxoSmithKline

Completed

Study FFR116365, an Open-label Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis

Rhinitis

Japan
State University of New York - Upstate Medical...

Completed

A Usability Assessment of Naloxone by Community Members

Drug Overdose
Manhattan Eye, Ear & Throat Hospital
Alcon Research

Terminated

Treatment of Rubeosis Iridis With Open-Label Anecortave Acetate Sterile Suspension ( 15 mg.).

Central Retinal Vein Occlusion | Severe Diabetic Retinopathy | Chronic Inflammation | Infectious Diseases

United States
GlaxoSmithKline

Completed

Study FFR116364, a Placebo-controlled Study of GW685698X in Paediatric Subjects With Perennial Allergic Rhinitis

Rhinitis, Allergic, Perennial

Japan
University of Chicago
GlaxoSmithKline

Completed

Mechanism of Action of Fluticasone Furoate in Childhood Obstructive Sleep Apnea Syndrome

Childhood Obstructive Sleep Apnea Syndrome (OSAS)

United States
Novartis

Completed

Effects of Octreotide Acetate on Circulating Levels of Chromogranin A in Advanced Prostate Cancer Patients

Prostate Cancer

Italy
Upsher-Smith Laboratories

Completed

An Efficacy and Safety Study of DFN-02 (Sumatriptan Nasal Spray 10 mg)

Migraine Headaches

United States
Tarsa Therapeutics, Inc.

Completed

A Study of Oral Calcitonin Given at Night to Healthy Postmenopausal Women

Phase 1 Pharmacodynamic Study

United States
Medical University Innsbruck

Withdrawn

ECT vs. Esketamine (ETES)

Major Depressive Disorder | Treatment Resistant Depression

Austria
University of Chicago
GlaxoSmithKline

Completed

Effect of Veramyst and Olopatadine 0.2% Opthalmic Solution on Allergy Symptoms

Seasonal Allergic Rhinitis

United States
GlaxoSmithKline

Completed

Study Evaluating the Effect of Fluticasone Furoate/ Vilanterol (FF/VI) Inhalation Powder Compared With Vilanterol (VI) Inhalation Powder on Bone Mineral Density (BMD) in Subjects With Chronic Obstructive Pulmonary Disease (COPD).

Pulmonary Disease, Chronic Obstructive

United States, Germany, Spain, Netherlands, Canada
University of Chicago
GlaxoSmithKline

Completed

Effect of Veramyst on the Nasal and Ocular Symptoms of the Early Reaction to Nasal Challenge With Allergen

Allergic Rhinitis

United States
University of Chicago
GlaxoSmithKline

Completed

Intranasal Steroids and the Nasal Ocular Response

Seasonal Allergic Rhinitis

United States
University Hospital, Bonn

Completed

Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin (ESMory)

Oxytocin | Memory | Estrogen | Fear Extinction | Emotion Processing

Germany
INSYS Therapeutics Inc

Completed

A Study to Compare Bioavailability of Naloxone Nasal Spray and Naloxone Hydrochloride (HCl) Intramuscular Injection (IM) in Healthy Volunteers

Healthy Volunteer

United States
GlaxoSmithKline

Completed

Study to Determine the Pharmacokinetics of GSK961081 and Fluticasone Furoate When Administered Alone or in Combination

Pulmonary Disease, Chronic Obstructive

Australia
GlaxoSmithKline

Completed

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

Asthma

United States, Russian Federation, Peru, Mexico
GlaxoSmithKline

Completed

To Investigate the Effects of Altering the Time of Day of Dosing (Morning or Evening) With Fluticasone Furoate 100 Micrograms Once Daily Administered Via a Dry Powder Inhaler in Subjects With Asthma

Asthma

Australia
GlaxoSmithKline

Completed

Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States, Germany, Japan, Poland, Romania, Russian Federation, Ukraine, Taiwan, Bulgaria, South Africa, Korea, Republic of
Johns Hopkins University
GlaxoSmithKline

Terminated

Compare the Effects of Fluticasone Furoate Nasal Spray vs Placebo in Patients With Nasal Polypoid Disease

Patients With Nasal Polyps
University of Iowa

No longer available

Treatment of Patients With Age-Related Macular Degeneration With Anecortave Acetate

Macular Degeneration

United States
Rush University Medical Center
Advanced Rx

Active, not recruiting

Potential for Cortisol Suppression With the Use of High Volume Nasal Mometasone Irrigations in Varying Dosages.

Chronic Rhinosinusitis (Diagnosis)

United States
Kerecis Ltd.

Completed

Viruxal Oral and Nasal Spray for Treating the Symptoms of COVID-19 (KONS-COVID19)

COVID-19

Iceland
Royal North Shore Hospital
Janssen-Cilag Pty Ltd

Recruiting

Positioning of Esketamine Treatment in the Real-world Management of Depression (PoET)

Major Depressive Disorder

Australia
GlaxoSmithKline

Completed

A 24-week Arterial Stiffness Study With Fluticasone Furoate/Vilanterol in COPD

Pulmonary Disease, Chronic Obstructive

United States, Germany, Philippines, Thailand, Korea, Republic of, Norway
GlaxoSmithKline

Completed

A 24-week Study of Fluticasone Furoate/Vilanterol Inhalation Powder in Subjects of Asian Ancestry With COPD

Pulmonary Disease, Chronic Obstructive

Taiwan, China, Philippines, Korea, Republic of
Hospices Civils de Lyon

Completed

Efficacy of a Timolol Nasal Spray as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT) - (TEMPO) (TEMPO)

Telangiectasia, Hereditary Hemorrhagic | Osler Rendu Disease

France
Linmarie Sikich
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)

Autism Spectrum Disorders

United States
Pontificia Universidade Católica do Rio Grande...
Conselho Nacional de Desenvolvimento Científico e Tecnológico; Secretaria Nacional...

Unknown

Use of Intranasal Oxytocin During Detoxification of Crack Cocaine

Cocaine-Related Disorders | Cocaine Withdrawal | Cocaine Smoking

Brazil
National Taiwan University Hospital

Completed

Effect of Local Treatment(Carrageenan Nasal Spray and PVP-I Mouthwash) in Reducing Viral Load in Patients With COVID-19 (LT-COVID19)

Covid19 | SARS-CoV 2 Infection

Taiwan
Evoke Pharma

Completed

Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic Gastroparesis

Diabetic Gastroparesis

United States
Karolinska Institutet

Recruiting

Experimental Study on Alcohol Use and Behavior in Young Adults (OXYCAC)

Alcohol Use Disorder

Sweden
University of Saskatchewan

Completed

Effect of Fluticasone Furoate on Methacholine Challenge

Asthma

Canada
GlaxoSmithKline

Completed

Pharmacokinetics and PharmacoDynamics of GW685698 in Paedeatric Asthmatic Patients

Asthma

United States
GlaxoSmithKline

Completed

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Asthma

Korea, Republic of, China, Philippines
Laboratoire de la Mer
EVAMED

Completed

Seawater Nasal Wash to Relieve COVID-19 Nasal Symptoms and Reduce SARS-CoV-2 Viral Load. (SeaCare)

SARS-CoV2 Infection (COVID-19) | URTI - Viral Upper Respiratory Tract Infection

France
GlaxoSmithKline

Completed

A Study to Evaluate the 24 Hour Spirometric Effect (FEV1) of Fluticasone Furoate/Vilanterol Inhalation Powder (100mcg Fluticasone Furoate (FF)/25mcg Vilanterol (VI)) Compared With Salmeterol/Fluticasone Propionate Inhalation Powder (50mcg Salmeterol/500mcg Fluticasone Propionate (FP))

Pulmonary Disease, Chronic Obstructive

France, Germany, Spain, Russian Federation, Belgium, Ukraine, Philippines, Italy, Poland

3

Subscribe